Lithium - Columbia Northwest Pharmaceuticals

Drug Profile

Lithium - Columbia Northwest Pharmaceuticals

Latest Information Update: 03 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Columbia Northwest Pharmaceuticals
  • Class Alkali metals; Antidepressants; Antimanics; Antipsychotics; Light metals
  • Mechanism of Action Adrenergic uptake modulators; Serotonin release stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Suicidal ideation

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 22 Apr 2010 Phase-II clinical trials in Suicidal ideation in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top